Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Hold” from Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have received a consensus recommendation of “Hold” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell rating, four have given a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company.

SONVY has been the subject of several recent analyst reports. Zacks Research raised shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Royal Bank Of Canada raised shares of Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th.

Sonova Stock Performance

Sonova stock opened at $50.55 on Monday. Sonova has a 52-week low of $47.55 and a 52-week high of $68.76. The company has a quick ratio of 0.91, a current ratio of 1.24 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average is $53.11 and its 200 day moving average is $54.24.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.